Gabriela Vazquez-Galicia
3755 Cote Ste. Catherine Road, H3T 1E2
Montreal, QC, Canada
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 29, 2022
Magnesium-sensitive upstream ORF controls PRL phosphatase expression to mediate energy metabolism.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 06, 2019
Metabolic rewiring beyond Warburg in chronic lymphocytic leukemia: How much do we actually know?
Journal: Critical reviews in oncology/hematology
Published: August 13, 2018
Ibrutinib Resistance Is Reduced by an Inhibitor of Fatty Acid Oxidation in Primary CLL Lymphocytes.
Journal: Frontiers in oncology
Published: July 05, 2018
Del11q-positive CLL lymphocytes exhibit altered glutamine metabolism and differential response to GLS1 and glucose metabolism inhibition.
Journal: Blood cancer journal
Published: September 15, 2017
eIF4AII is dispensable for miRNA-mediated gene silencing.
Journal: RNA (New York, N.Y.)
Published: April 16, 2015
The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo.
Journal: Immunity
Published: January 15, 2014
Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4A.
Journal: Blood cancer journal
Published: May 15, 2013
Inhibitors of translation targeting eukaryotic translation initiation factor 4A.
Journal: Methods in enzymology
Published: June 21, 2012
A cellular response linking eIF4AI activity to eIF4AII transcription.
Journal: RNA (New York, N.Y.)
Published: May 17, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026